B-Lymphocyte Antigen CD20 (MS4A1) Antibody

Este producto es parte de MS4A1 - membrane spanning 4-domains A1
Product Graph
299€ (0.1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
B-Lymphocyte Antigen CD20 (MS4A1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx139192
tested applications
FCM, IP

Description

CD20 Antibody (Azide free) is a Mouse Monoclonal against CD20.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
B-Lymphocyte Antigen CD20 (MS4A1)
Host
Mouse
Reactivity
Human, Pig, Cow
Recommended Dilution
FCM: 1-5 μg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1
Clone ID
S860
Purity
> 95% (SDS-PAGE)
Purification
Purified by Protein A affinity chromatography.
Size 1
0.1 mg
Tested Applications
FCM, IP
Buffer
Azide free PBS, approx. pH 7.4; 0.2 µm filter sterilized.
Availability
Shipped within 5-12 working days.
Storage
Store at 2-8°C. Do not freeze.
Dry Ice
No
UniProt ID
P11836
Gene ID
931
Alias
B1,S7,Bp35,CD20,FMC7,CVID5,LEU-16,B-lymphocyte antigen CD20,B-lymphocyte surface antigen B1,Leukocyte surface antigen Leu-16,Membrane-spanning 4-domains subfamily A member 1
Background
Antibody anti-MS4A1
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

MS4A1, also known as CD20, is a membrane-bound protein that plays a key role in the regulation of B-cell development, activation, and differentiation. It is predominantly expressed on the surface of B lymphocytes from the pre-B cell stage through to the mature B cell stage, and its expression is lost once B cells differentiate into plasma cells. CD20 is widely studied for its role in both normal immune function and its involvement in a variety of B-cell-related diseases, including non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), and autoimmune diseases. MS4A1 is a member of the membrane-spanning 4A (MS4A) family of proteins, which includes several proteins with similar structural features, although their specific functions may differ across cell types and tissues. CD20 has become a major therapeutic target, particularly in B-cell depletion therapies, due to its restricted expression pattern and its role in the immune response. The development of anti-CD20 monoclonal antibodies, such as rituximab, has revolutionized the treatment of B-cell malignancies and certain autoimmune conditions.

Related Products

EH14877

Human MS4A1(B-lymphocyte antigen CD20) ELISA Kit

Ver Producto
EM1914

Mouse CD20 (B-lymphocyte antigen CD20) ELISA Kit

Ver Producto
FNab01440

anti- CD20 antibody

CD20 is a 33-37 kDa transmembrane phosphoprotein. CD20 is a B-lymphocyte surface molecule that is widely expressed during B-cell ontogeny, from early pre-B-cell developmental stages until final differentiation into plasma cells. CD20 functions as calcium-permeable cation channel. It is involved in the regulation of B-cell activation and proliferation. CD20 serves as a useful target for antibody-mediated therapeutic depletion of B-cells.

Ver Producto